Calan

Calan 80mg: Uses, Dosage, Side Effects & Warnings

Introduction to Calan

Calan, also known by its generic name verapamil hydrochloride, is a calcium channel blocker medication used to treat various cardiovascular conditions such as hypertension (high blood pressure), angina (chest pain), and certain heart rhythm disorders. Calan works by relaxing the muscles in your blood vessels, thereby lowering blood pressure and improving blood flow to the heart.

Pharmacology

Calan belongs to the class of drugs known as calcium channel blockers. It acts by inhibiting the influx of calcium ions into vascular smooth muscle cells and cardiac muscle cells during depolarization, resulting in the relaxation of blood vessels and decreased myocardial contractility. This mechanism of action contributes to its antihypertensive and anti-anginal effects.

Medical Uses

Calan is primarily used for the treatment of hypertension and angina pectoris. It may also be used in the management of certain heart rhythm disorders such as supraventricular tachycardia. By lowering blood pressure and improving blood flow to the heart, Calan helps reduce the risk of complications such as heart attacks, strokes, and kidney problems.

Dosage and Administration

Calan is available in oral tablet form, typically in dosages of 40 mg, 80 mg, and 120 mg. Extended-release formulations such as Calan SR are also available. The usual starting dose for adults is 80 mg three times daily, which may be adjusted based on individual response and tolerability. Intravenous administration of verapamil may be used in certain hospital settings under close medical supervision.

Package Insert / Prescribing Information

The package insert for Calan provides detailed information on indications for use, contraindications, warnings, and precautions. It is essential for healthcare professionals to thoroughly review this information before prescribing Calan to ensure safe and appropriate use. Patients should also read the patient information leaflet provided with their medication.

Side Effects and Adverse Reactions

Common side effects of Calan include constipation, dizziness, fatigue, nausea, and headache. More serious adverse reactions may include heart rhythm disturbances, low blood pressure, and allergic reactions. Patients should inform their healthcare provider if they experience any concerning symptoms while taking Calan.

Drug Interactions

Calan may interact with various medications, including beta-blockers, digoxin, and certain antiarrhythmics. It is important for patients to inform their healthcare provider about all medications they are taking to avoid potential drug interactions. Grapefruit and grapefruit juice should be avoided while taking Calan as they can increase the risk of side effects.

Calan in Special Populations

The use of Calan in special populations such as pediatric patients, geriatric patients, and pregnant or breastfeeding women requires careful consideration and individualized treatment decisions. Healthcare providers should assess the potential benefits and risks of using Calan in these populations and provide appropriate monitoring and dose adjustments as needed.

Overdose and Management

Symptoms of Calan overdose may include severe hypotension, bradycardia, and cardiac conduction disturbances. In case of suspected overdose, immediate medical attention is required. Treatment may involve supportive measures such as intravenous fluids, vasopressors, and cardiac monitoring. The use of calcium salts and glucagon may be considered in cases of severe overdose.

Buying and Affordability

Calan is available by prescription at most pharmacies. Prices may vary depending on the dosage, quantity, and insurance coverage. Patients can compare prices at different pharmacies and explore options such as generic alternatives, prescription discount programs, and manufacturer coupons to help manage the cost of their medication.

Patient Information

Patients should take Calan exactly as prescribed by their healthcare provider. It is important to follow any special instructions, such as taking the medication with food or avoiding certain activities. Patients should not stop taking Calan abruptly without consulting their healthcare provider, as this may lead to adverse effects. Regular follow-up appointments and monitoring are essential to assess treatment response and make any necessary adjustments.

Regulatory and Legal Information

Calan is approved by the U.S. Food and Drug Administration (FDA) for the treatment of hypertension, angina pectoris, and certain arrhythmias. It is manufactured by various pharmaceutical companies and is subject to regulatory oversight to ensure safety, efficacy, and quality. Legal considerations such as prescription requirements and controlled substance scheduling may vary by jurisdiction.

Clinical Studies and Research

Numerous clinical studies have been conducted to evaluate the efficacy and safety of Calan in various cardiovascular conditions. These studies have demonstrated its effectiveness in lowering blood pressure, improving angina symptoms, and managing certain heart rhythm disorders. Ongoing research continues to explore the long-term effects and potential new indications for Calan.

Healthcare Providers’ Information

Healthcare providers should follow established guidelines and best practices when prescribing Calan. This includes assessing patient suitability, considering potential contraindications and drug interactions, and providing appropriate patient counseling. Regular monitoring of blood pressure, heart rate, and other relevant parameters is crucial to ensure safe and effective use of Calan.

Calan vs. Other Medications

Calan belongs to the class of calcium channel blockers, which includes other medications such as amlodipine, diltiazem, and nifedipine. While these medications share similar mechanisms of action, they may have different pharmacokinetic properties, indications, and side effect profiles. Healthcare providers should consider individual patient factors and treatment goals when selecting the most appropriate calcium channel blocker or alternative antihypertensive therapy.

Visual and Physical Description

Calan tablets are typically round, film-coated, and imprinted with the dosage strength. The 80 mg tablets are white to off-white in color. Calan is available in various packaging options, including bottles and blister packs. It is important to store Calan at room temperature, away from moisture and heat, and to keep it out of reach of children.

Calan